Stephen Hoge Moderna, Inc. (MRNA) insider trading activity

MRNA Quotes by TradingView

Stephen Hoge is President of Moderna, Inc.. Currently has a direct ownership of 1.44 Million shares of MRNA, which is worth approximately $94.9 Million. The most recent transaction as insider was on Sep 03, 2024, when has been sold 318 shares (Common Stock) at a price of $76.99 per share, resulting in proceeds of $24,482. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.44M
0.97% 3M change
8.33% 12M change
Total Value Held $94.9 Million

Stephen Hoge Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 03 2024
SELL
Open market or private sale
$24,482 $76.99 p/Share
318 Reduced 0.02%
1,443,002 Common Stock
Aug 30 2024
BUY
Exercise of conversion of derivative security
-
652 Added 0.05%
1,443,320 Common Stock
Aug 29 2024
SELL
Open market or private sale
$23,409 $78.03 p/Share
300 Reduced 0.02%
1,442,668 Common Stock
Aug 28 2024
BUY
Exercise of conversion of derivative security
-
611 Added 0.04%
1,442,968 Common Stock
Aug 12 2024
SELL
Open market or private sale
$21,361 $84.1 p/Share
254 Reduced 0.02%
1,442,357 Common Stock
Aug 09 2024
BUY
Exercise of conversion of derivative security
-
522 Added 0.04%
1,442,611 Common Stock
Jul 15 2024
SELL
Open market or private sale
$1,816,800 $121.12 p/Share
15,000 Reduced 1.03%
1,442,089 Common Stock
Jun 17 2024
SELL
Open market or private sale
$2,072,400 $138.16 p/Share
15,000 Reduced 1.02%
1,457,089 Common Stock
Jun 03 2024
SELL
Open market or private sale
$47,704 $140.72 p/Share
339 Reduced 0.02%
1,472,089 Common Stock
May 31 2024
BUY
Exercise of conversion of derivative security
-
651 Added 0.04%
1,472,428 Common Stock
May 29 2024
SELL
Open market or private sale
$49,274 $144.5 p/Share
341 Reduced 0.02%
1,471,777 Common Stock
May 28 2024
BUY
Exercise of conversion of derivative security
-
610 Added 0.04%
1,472,118 Common Stock
May 15 2024
SELL
Open market or private sale
$1,912,350 $127.49 p/Share
15,000 Reduced 1.01%
1,471,508 Common Stock
May 10 2024
SELL
Open market or private sale
$30,844 $120.96 p/Share
255 Reduced 0.02%
1,486,508 Common Stock
May 09 2024
BUY
Exercise of conversion of derivative security
-
522 Added 0.04%
1,486,763 Common Stock
Apr 15 2024
SELL
Open market or private sale
$1,575,300 $105.02 p/Share
15,000 Reduced 1.0%
1,486,241 Common Stock
Mar 15 2024
SELL
Open market or private sale
$1,547,550 $103.17 p/Share
15,000 Reduced 0.99%
1,501,241 Common Stock
Mar 04 2024
SELL
Open market or private sale
$29,151 $94.34 p/Share
309 Reduced 0.02%
1,516,241 Common Stock
Mar 01 2024
BUY
Exercise of conversion of derivative security
-
652 Added 0.04%
1,516,550 Common Stock
Feb 29 2024
SELL
Open market or private sale
$225,833 $94.57 p/Share
2,388 Reduced 0.16%
1,515,898 Common Stock
Feb 28 2024
BUY
Exercise of conversion of derivative security
-
4,853 Added 0.32%
1,518,286 Common Stock
Feb 22 2024
SELL
Open market or private sale
$1,500,000 $100.0 p/Share
15,000 Reduced 0.98%
1,513,433 Common Stock
Feb 16 2024
SELL
Open market or private sale
$936,972 $88.88 p/Share
10,542 Reduced 0.69%
1,528,433 Common Stock
Feb 14 2024
BUY
Grant, award, or other acquisition
-
22,694 Added 1.45%
1,538,975 Common Stock
Feb 12 2024
SELL
Open market or private sale
$26,213 $86.23 p/Share
304 Reduced 0.02%
1,516,281 Common Stock

Also insider at

AXLA
Axcella Health Inc. Healthcare
Director
Stephen Hoge

Stephen Hoge

President
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRNA